Stem Cell Therapy for Diabetes Mellitus

"Despite establishing its clinical efficacy and safety in some phase I/II trials, utilization of stem cell therapy for clinical use needs further research and standardization. Current research hotspots in stem cell therapy for DM involve identifying and optimizing the ideal source of stem cells for differentiation into insulin-secreting beta cells at the site of action. Apart from identifying the optimal source and understanding the stem cell function, future research into the appropriate dosage, route, and in vivo differentiation kinetics is also needed."

(Read this article to understand the use of scientometric research trend analysis.)

Muthu S, Jeyaraman M, Jeyaraman N, Rajendran RL, Gangadaran P. Where Do We Stand in Stem Cell Therapy for the Management of Diabetes Mellitus?-A Scientometric Research Trend Analysis from 1990 to 2020. Bioengineering (Basel). 2021 Oct 26;8(11):159. doi: 10.3390/bioengineering8110159. PMID: 34821725; PMCID: PMC8615097.